Score Overview
Explore the 2021 public Archive ranking →
Where Fate Therapeutics Inc has ranked, year by year
Showing 1 year ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- FATE
2019: 81.6% · 2021: 55.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-30 | $ 2.37 | — |
1 Year2025-09-30 | $ 1.26 | 88.10% |
5 Years2021-09-30 | $ 59.27 | -96.00% |
10 Years2016-09-30 | $ 3.12 | -24.04% |
All Time2013-10-01 | $ 6.62 | -64.20% |
| Period | Last Price2026-09-30 | 1 Year2025-09-30 | 5 Years2021-09-30 | 10 Years2016-09-30 | All Time2013-10-01 |
|---|---|---|---|---|---|
| Price | $ 2.37 | $ 1.26 | $ 59.27 | $ 3.12 | $ 6.62 |
| Return | — | 88.10% | -96.00% | -24.04% | -64.20% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 6M | -$ 129M | $ 174M |
| 2025 | $ 6M | -$ 136M | $ 203M |
| 2024 | $ 13M | -$ 186M | $ 279M |
| 2023 | $ 63M | -$ 160M | $ 315M |
| 2022 | $ 96M | -$ 255M | $ 436M |
| 2021 | $ 55M | -$ 212M | $ 615M |
| 2020 | $ 31M | -$ 173M | $ 482M |
| 2019 | $ 10M | -$ 98M | $ 221M |
| 2018 | $ 4M | -$ 66M | $ 201M |
| 2017 | $ 4M | -$ 42M | $ 100M |
| 2016 | $ 4M | -$ 33M | $ 92M |
| 2015 | $ 2M | -$ 29M | $ 64M |
| 2014 | $ 0.00 | -$ 25M | $ 49M |
| IPO2013 | $ 971K | -$ 20M | $ 54M |
Fate Therapeutics Inc fundamental performance
Between 2020 and 2025, revenue declined from $ 31M to $ 6M and net income went from -$ 173M to -$ 136M. Revenue increased in 1 of those 5 years; net income in 3.
Across Fate Therapeutics Inc's full reported history, from 2013 to 2025, revenue grew from $ 971K to $ 6M and net income went from -$ 20M to -$ 136M. Revenue increased in 54% of the years measured; net income in 23%.
Fate Therapeutics Inc currently holds a 5-year HDB Score of 4.1 out of 10. How the HDB Score is calculated.
Membership
Continue FATE’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
